Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Furnari

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Nature Communications|May 26, 2018
Publisher Correction: PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3Jorge A Benitez, Jianhui Ma, Matteo D'Antonio, et al.
Nature Communications|May 13, 2017
PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3Jorge A Benitez, Jianhui Ma, Matteo D'Antonio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targetingJohn C Sok, Francesca M Coppelli, Sufi M Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activityRushika M Perera, Yoshitaka Narita, Frank B Furnari, et al.
Neuro-Oncology|July 21, 2025
BRD2 Bromodomain-Mediated Regulation of Cell State Plasticity Modulates Therapy Response in GlioblastomaRaghavendra Vadla, Brett Taylor, Yohei Miyake, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2016
Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/SynteninTimothy P Kegelman, Bainan Wu, Swadesh K Das, et al.
Cancer Research|July 14, 1998
Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndromeJ M Carethers, F B Furnari, A F Zigman, et al.
Cancer Cell|May 16, 2006
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humansDaniel R Carrasco, Tim Fenton, Kumar Sukhdeo, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2013
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapiesAkio Iwanami, Beatrice Gini, Ciro Zanca, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2012
Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesisHaizhong Feng, Bo Hu, Michael J Jarzynka, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Nature Communications|May 26, 2018
Publisher Correction: PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3Jorge A Benitez, Jianhui Ma, Matteo D'Antonio, et al.
Nature Communications|May 13, 2017
PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3Jorge A Benitez, Jianhui Ma, Matteo D'Antonio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targetingJohn C Sok, Francesca M Coppelli, Sufi M Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activityRushika M Perera, Yoshitaka Narita, Frank B Furnari, et al.
Neuro-Oncology|July 21, 2025
BRD2 Bromodomain-Mediated Regulation of Cell State Plasticity Modulates Therapy Response in GlioblastomaRaghavendra Vadla, Brett Taylor, Yohei Miyake, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2016
Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/SynteninTimothy P Kegelman, Bainan Wu, Swadesh K Das, et al.
Cancer Research|July 14, 1998
Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndromeJ M Carethers, F B Furnari, A F Zigman, et al.
Cancer Cell|May 16, 2006
The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humansDaniel R Carrasco, Tim Fenton, Kumar Sukhdeo, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2013
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapiesAkio Iwanami, Beatrice Gini, Ciro Zanca, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2012
Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesisHaizhong Feng, Bo Hu, Michael J Jarzynka, et al.
Pageof 12